Company Innopharma International Srl with Fiscal Code 26893952
recorded a turnover of 2024 of
- ,
with a net profit of
-6.026
and having an average number of employees of
- .
The company operates in the field of Cercetare-dezvoltare in alte stiinte naturale si inginerie having the NACE code 7219.
Sales - Ron
Sales, Profit, Employees, Total Income, Financial Results -
Innopharma International Srl
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Sales - EUR
124.473
111.349
112.044
18.000
17.983
17.010
4.373
6.256
2.089
0
Total Income - EUR
125.291
112.077
113.224
18.163
18.050
17.018
4.377
6.256
2.179
31
Total Expenses - EUR
115.937
102.582
97.242
27.047
22.612
12.292
6.446
6.030
6.363
6.057
Gross Profit/Loss - EUR
9.354
9.495
15.982
-8.884
-4.562
4.726
-2.069
227
-4.185
-6.026
Net Profit/Loss - EUR
9.354
9.495
14.274
-9.064
-4.742
4.216
-2.200
39
-4.185
-6.026
Employees
3
3
3
1
1
1
1
0
0
0
The table presents the most important indicators of the company from the Profit and Loss Account for the last 10 years of activity as found at the Ministry of Finance. The data provides the evolution of the company during this period regarding the increases and possibly decreases recorded.
Check the financial reports for the company - Innopharma International Srl
Financial Rating - INNOPHARMA INTERNATIONAL SRL
See the company's note based on the submitted financial data, relative to the industry of which it is a part.
Financial Rating
Payment Limits - Innopharma International Srl
See the company's payment capacity for situations in which you conclude contracts with payment terms.
Check Payment Limits
Prob. of insolvency - Innopharma International Srl
It determines the risk of insolvency based on the submitted accounting balance.
Insolvency Probability
Financial Reports - Innopharma International Srl
Check all the financial reports of the company and know the risks in collaboration with it.
Check Financial Reports
Financial Analysis Reports provide a clear and comprehensive view of a company's financial activity. In addition to presenting financial data, the reports analyze this data so that any user can understand whether the results are positive or less favorable. The Financial Rating provides an analysis based on the most important financial ratios, including liquidity, solvency, and profitability. Payment Limits represent the maximum amounts for which a company can offer goods or services on credit to its clients. The Probability of Insolvency presents the theoretical probability that a company may not be able to meet its financial obligations towards its creditors, i.e., suppliers and financial institutions.
Debts, Equity, Inventories, Receivables, Accounts, Assets -
Innopharma International Srl - CUI 26893952
2015
2016
2017
2018
2019
2020
2021
2022
2023
2024
Fixed Assets
2.196
1.976
1.829
585
574
563
550
552
550
547
Current Assets
25.177
62.019
27.284
19.251
15.944
18.718
12.613
13.273
15.624
15.981
Inventories
0
0
0
0
0
0
0
0
0
0
Receivables
23.454
61.640
26.347
17.492
15.944
18.674
12.592
13.076
13.486
13.855
Cash
1.723
378
937
1.759
0
44
21
197
2.138
2.126
Shareholders Funds
6.262
10.399
24.496
14.983
9.952
13.626
11.123
11.197
6.978
913
Social Capital
9.494
9.397
9.238
9.068
8.893
8.724
8.531
8.557
8.531
8.484
Debts
21.966
53.731
4.918
4.852
6.567
5.655
2.040
2.628
9.196
15.616
Income in Advance
0
40.448
0
0
0
0
0
0
0
0
Exchange rate - RON
4.9743
4.9465
4.9315
4.9468
4.8371
4.7454
4.6535
4.5681
4.4908
4.445
Main CAEN
"7219 - 7219"
CAEN Financial Year
7219
The table presents the company's Balance Sheet structure for the last 10 years. Current Assets recorded a value of
15.981 euro in 2024 which includes Inventories of
0 euro, Receivables of
13.855 euro and cash availability of
2.126 euro.
The company's Equity was valued at
913 euro, while total Liabilities amounted to
15.616 euro.
Equity decreased by -6.026 euro, from 6.978 euro in 2023, to 913 in 2024.
Similar services useful for checking companies and business development.
SellNet
Get the contact details for any company and get in touch with it.
Sectoral Studies
Knows the market and develops its own development strategies according to sectorial data.
Databases
Export in excel files the data of the companies selected according to the desired criteria.
Import - Export
Find importers and exporters according to the type of activity and the countries in which they carry it out.
Similar services represent services associated with companies that allow for a better analysis of clients and suppliers. Company Contacts help you get in touch with the desired companies. Sector Studies provide an overview of an industry, the most important competitors, and the geographical distribution of companies. Company Lists allow you to attract new clients, while Import-Export services give you access to companies engaged in such activities.
Comments - Innopharma International Srl